Form 6-K ASTRAZENECA PLC For: Feb 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
AstraZeneca (AZN) Misses Q3 EPS by 9c
February 5, 2015 8:49 AM ESTAstraZeneca (NYSE: AZN) reported Q3 EPS of $0.76, $0.09 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $6.68 billion versus the consensus estimate of $6.68 billion.
Pascal Soriot, Chief Executive Officer, commenting on the results, said:
2014 was a remarkable year for AstraZeneca. We achieved a record six product... More
